|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-04
|
$347,563
|
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-04
|
$516,979
|
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-02
|
$414,072
|
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$719,839
|
$215,952
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Web-based Smoking Cessation Program for Tribal College Students
|
5R01CA174481-05
|
$556,175
|
|
CHOI, WON
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Web-based Physical Activity Intervention for Children with ALL
|
5R01CA193478-02
|
$869,905
|
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-03
|
$514,474
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Visual Media Influences on Adolescent Smoking Behavior
|
5R01CA077026-18
|
$521,341
|
|
SARGENT, JAMES
|
DARTMOUTH COLLEGE
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
5R44CA153474-03
|
$519,583
|
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Virtual Transportation as a Strategy to Reduce Resistance to Cigarette and e-Cigarette Graphic Health Warnings in Adolescents and Young Adults
|
1R01CA214587-01
|
|
|
BLANTON, HART
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,126,266
|
$56,313
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-04
|
$590,334
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-18
|
$800,773
|
|
RATHMELL, WENDY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-06
|
$646,350
|
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Using the RE-AIM Model to Translate Distress Screening into Cancer Care
|
5R25CA177553-05
|
$275,749
|
|
MCCORKLE, RUTH
|
YALE UNIVERSITY
|
|
Using the Collaborative Cross for Model Studies of Intestinal Cancer
|
5R21CA202496-02
|
$169,650
|
|
SIRACUSA, LINDA
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
1R21CA208921-01A1
|
$200,807
|
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester-NCORP Research Base
|
5UG1CA189961-04
|
$3,781,235
|
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
University of Maryland, Baltimore Biomarker Reference Laboratory
|
5U24CA115091-12
|
$456,438
|
|
STASS, SANFORD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding resistance in the HER2-HER3 tumor drive
|
5R01CA122216-10
|
$298,554
|
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-04
|
$377,699
|
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Understanding how graphic warnings on cigarette packs increase quit intentions
|
5F31CA196037-02
|
$4,928
|
|
HALL, MARISSA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Understanding Esophageal Adenocarcinoma Progression Using Inflammatory and Neoplastic Extracellular Matrix Hydrogels
|
5F31CA210694-02
|
$40,302
|
|
SALDIN, LINDSEY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell
|
5F32CA210421-02
|
$56,694
|
|
DANAI, LAURA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding causal effects of a treatment on survival in observational studies with unmeasured confounding and an application to effect of PMRT on breast cancer patients
|
1R03CA208387-01A1
|
$96,251
|
|
YANG, FAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Breast Cancer Metastasis to Lymph Node
|
5R21CA199621-02
|
$168,563
|
|
MOHAMMED, SULMA
|
PURDUE UNIVERSITY
|
|
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
|
2R01CA154451-04A1
|
$498,703
|
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
Ultrasound imaging and enhanced therapeutic response
|
5R01CA134659-09
|
$499,000
|
|
FERRARA, KATHERINE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-08
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
|
5R01CA175480-05
|
$327,536
|
|
CHENG, ZHILIANG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
5R01CA200574-02
|
$359,138
|
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
|
5R01CA198096-03
|
$429,377
|
|
STRAUBINGER, ROBERT
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
5P01CA067166-20
|
$1,585,768
|
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Translational Approaches to Melanoma Prevention in Children at High Genetic Risk
|
5K07CA196985-03
|
$136,555
|
|
WU, YELENA
|
UNIVERSITY OF UTAH
|
|
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
|
5R01CA168814-05
|
$69,085
|
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
|
5R35CA197573-03
|
$888,930
|
|
FIORE, MICHAEL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Transforming fluorescence lifetime imaging microscopy into a fast and simple platform for high-content molecular analysis
|
5R21CA206953-02
|
$260,846
|
|
HAUN, JERED
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-17
|
$805,200
|
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Program in Cancer-related Population Sciences
|
2T32CA094061-16
|
$32,650
|
|
NEUGUT, ALFRED
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Training Physician Scientists in Pediatric Oncology
|
5T32CA009659-22
|
$136,153
|
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Training in Translational Research of Lung, Head and Neck Cancer
|
5T32CA174648-05
|
$425,474
|
|
WANG, XIAO-JING
|
UNIVERSITY OF COLORADO DENVER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-33
|
$570,788
|
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
Trace element supplementation to enhance calcium-mediated suppression of human colon adenoma growth
|
5R21CA201782-02
|
$202,275
|
|
VARANI, JAMES
|
UNIVERSITY OF MICHIGAN
|
|
Towards Understanding Prostate Cancer Heterogeneity
|
5R01CA125612-09
|
$372,410
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.
|
5R44CA165320-05
|
$962,653
|
|
DURIC, NEBOJSA
|
DELPHINUS MEDICAL TECHNOLOGIES, INC.
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-21
|
$256,101
|
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY
|
Total relevant funding to Autoimmune Diseases for this search: $6,827,518
|